HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuya Someno Selected Research

hygrolidin

10/2002Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuya Someno Research Topics

Disease

9Neoplasms (Cancer)
02/2015 - 10/2002
6Prostatic Neoplasms (Prostate Cancer)
04/2015 - 07/2003
2Atopic Dermatitis (Atopic Eczema)
10/2010 - 02/2009
2Neoplasm Metastasis (Metastasis)
05/2010 - 03/2010
1Weight Gain
04/2014
1Hypoxia (Hypoxemia)
11/2006
1Carcinoma (Carcinomatosis)
05/2004
1Colonic Neoplasms (Colon Cancer)
10/2002

Drug/Important Bio-Agent (IBA)

3AndrogensIBA
04/2015 - 07/2003
2CeramidasesIBA
10/2010 - 02/2009
1Androgen Receptors (Androgen Receptor)IBA
04/2015
1AnthraquinonesIBA
02/2015
1TrehaloseIBA
04/2014
1Citric Acid (Citrate)FDA LinkGeneric
10/2010
1Antineoplastic Agents (Antineoplastics)IBA
06/2010
1NBRI16716AIBA
06/2010
1Receptor for Advanced Glycation End ProductsIBA
05/2010
1Mitogen-Activated Protein KinasesIBA
05/2010
1HMGB1 Protein (HMG1)IBA
05/2010
1cytostatinIBA
03/2010
1rubratoxinsIBA
03/2010
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
03/2010
1L 644711 (B-3(+))IBA
05/2009
1atpenin A4IBA
05/2009
1CeramidesIBA
02/2009
1ceramidastinIBA
02/2009
1GlucosidesIBA
07/2008
1terreinIBA
07/2008
1angiogeninIBA
07/2008
1tartrolone CIBA
11/2006
1Oxygen (Dioxygen)IBA
11/2006
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2004
1Fluorouracil (Carac)FDA LinkGeneric
05/2004
1rhodanile blueIBA
05/2004
1Keratins (Keratin)IBA
05/2004
1Coloring Agents (Dyes)IBA
05/2004
1phthoxazolinIBA
05/2004
1hygrolidinIBA
10/2002

Therapy/Procedure

2Therapeutics
07/2008 - 11/2006